» Articles » PMID: 25064163

Development of a New Risk Score for Hospital-associated Venous Thromboembolism in Noncritically Ill Children: Findings from a Large Single-institutional Case-control Study

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2014 Jul 28
PMID 25064163
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine risk factors for pediatric hospital-associated venous thromboembolism (HA-VTE) in noncritically ill children to derive a novel HA-VTE risk model for this population.

Study Design: Patients with HA-VTE were identified retrospectively via the electronic health record at All Children's Hospital Johns Hopkins Medicine from April 10, 2013 through January 1, 2006. Seven contemporaneous, noncritically ill control children were randomly selected for each case of HA-VTE. The association between putative risk factors and HA-VTE was estimated with ORs and 95% CIs, which were calculated using the Wald method. A P-value threshold ≤.2 was used in univariate analysis for inclusion into a multivariate (adjusted) model.

Results: Fifty cases of HA-VTE occurred in noncritically ill children. The presence of a central venous catheter (OR 27.67, 95% CI, 8.40-91.22), infection (OR 10.40, 95% CI, 3.46-31.25), and length of stay ≥4 days (OR 5.26, 95% CI, 1.74-15.88) were found to be statistically significant risk factors for HA-VTE. An 8-point risk score was derived in which scores of 8 points, 7 points, and ≤6 points corresponded to venous thromboembolism risks of 12.5%, 1.1%, and 0.1%, respectively.

Conclusion: The presence of a central venous catheter, infection, and length of stay ≥4 days are significant risk factors for HA-VTE in noncritically ill children, forming the basis for a new risk score that could inform venous thromboembolism prophylaxis decision-making. These findings warrant prospective validation.

Citing Articles

Model-Guided Decision-Making for Thromboprophylaxis and Hospital-Acquired Thromboembolic Events Among Hospitalized Children and Adolescents: The CLOT Randomized Clinical Trial.

Walker S, French B, Moore R, Domenico H, Wanderer J, Mixon A JAMA Netw Open. 2023; 6(10):e2337789.

PMID: 37831448 PMC: 10576217. DOI: 10.1001/jamanetworkopen.2023.37789.


Development and validation of a nomogram model for central venous access device-related thrombosis in hospitalized children.

Tian L, Su Y, Gao H, Wang L, Zeng J, Yang Q Eur J Pediatr. 2023; 182(11):4909-4919.

PMID: 37606700 DOI: 10.1007/s00431-023-05078-x.


Use of a real-time risk-prediction model to identify pediatric patients at risk for thromboembolic events: study protocol for the Children's Likelihood Of Thrombosis (CLOT) trial.

Walker S, French B, Moore R, Domenico H, Wanderer J, Balla S Trials. 2022; 23(1):901.

PMID: 36273203 PMC: 9588222. DOI: 10.1186/s13063-022-06823-7.


Risk of venous thromboembolism in pediatric hospitalized patients undergoing noncardiac surgery: A report from the Children's Hospital-Acquired Thrombosis consortium.

Stephens E, Nguyen A, Jaffray J, Branchford B, Amankwah E, Goldenberg N Res Pract Thromb Haemost. 2022; 6(7):e12810.

PMID: 36254253 PMC: 9561357. DOI: 10.1002/rth2.12810.


A Real-time Risk-Prediction Model for Pediatric Venous Thromboembolic Events.

Walker S, Creech C, Domenico H, French B, Byrne D, Wheeler A Pediatrics. 2021; 147(6).

PMID: 34011634 PMC: 8168609. DOI: 10.1542/peds.2020-042325.


References
1.
Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B . A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol. 2011; 58(6):645-51. DOI: 10.1016/j.jacc.2011.01.061. View

2.
Takemoto C, Sohi S, Desai K, Bharaj R, Khanna A, McFarland S . Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. J Pediatr. 2013; 164(2):332-8. DOI: 10.1016/j.jpeds.2013.10.025. View

3.
Kahn S, Lim W, Dunn A, Cushman M, Dentali F, Akl E . Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e195S-e226S. PMC: 3278052. DOI: 10.1378/chest.11-2296. View

4.
Biss T, Brandao L, Kahr W, Chan A, Williams S . Clinical features and outcome of pulmonary embolism in children. Br J Haematol. 2008; 142(5):808-18. DOI: 10.1111/j.1365-2141.2008.07243.x. View

5.
Goldenberg N, Donadini M, Kahn S, Crowther M, Kenet G, Nowak-Gottl U . Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica. 2010; 95(11):1952-9. PMC: 2966919. DOI: 10.3324/haematol.2010.026989. View